MedTrace Logo

A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease

NCT05492994 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2025-08-05

No results posted yet for this study

Summary

The main objectives of this imaging biomarker study are to assess the annual lung function change in patients with progressive fibrosing interstitial lung disease (PF-ILD) including idiopathic pulmonary fibrosis (IPF), with Usual Interstitial Pneumonia (UIP) or probable UIP Computer Tomography (CT) pattern, and to monitor lung structural changes.

Conditions

  • Lung Diseases, Interstitial

Interventions

DIAGNOSTIC_TEST

Spirometry

Pulmonary function test

DIAGNOSTIC_TEST

Diffusing Capacity of the Lung for Carbon Monoxide (DLCO)

Pulmonary function test

DIAGNOSTIC_TEST

Magnetic Resonance Imaging

Magnetic Resonance Imaging

DIAGNOSTIC_TEST

Chest Computer Tomography

Chest Computer Tomography

DIAGNOSTIC_TEST

Blood biomarker analysis

Blood biomarker analysis

Sponsors & Collaborators

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-19
Primary Completion
2026-06-09
Completion
2026-06-09

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05492994 on ClinicalTrials.gov